HealthStream (NASDAQ:HSTM) Rating Lowered to “Hold” at Wall Street Zen

HealthStream (NASDAQ:HSTM) was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued on Saturday, Wall Street Zen reports.

Several other research firms have also recently commented on HSTM. Canaccord Genuity Group upped their price target on HealthStream from $24.00 to $27.00 and gave the company a “hold” rating in a report on Tuesday, July 21st. Weiss Ratings upgraded HealthStream from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, October 8th. Finally, Freedom Capital upgraded HealthStream to a “hold” rating in a research report on Tuesday, October 13th. One equities research analyst has rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $27.00.

HealthStream Stock Performance

NASDAQ:HSTM opened at $33.13 on Friday. The firm’s 50-day moving average is $29.86 and its 200-day moving average is $26.65. The company has a market cap of $967.89 million, a price-to-earnings ratio of 46.01, a PEG ratio of 3.83 and a beta of 0.42. HealthStream has a 52-week low of $19.50 and a 52-week high of $34.48.

HealthStream (NASDAQ:HSTM) last released its earnings results on Monday, August 3rd. The technology company reported $0.23 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.06. HealthStream had a net margin of 6.60% and a return on equity of 6.81%. The business had revenue of $83.73 million during the quarter, compared to analysts’ expectations of $80.82 million. Equities analysts predict that HealthStream will post 0.72 EPS for the current year.

Insider Transactions at HealthStream

In other HealthStream news, CEO Robert Frist, Jr. sold 144,068 shares of the business’s stock in a transaction on Monday, September 14th. The shares were sold at an average price of $29.50, for a total value of $4,250,006.00. Following the sale, the chief executive officer owned 3,907,038 shares of the company’s stock, valued at $115,257,621. The trade was a 3.56% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 20.40% of the stock is owned by company insiders.

Hedge Funds Weigh In On HealthStream

A number of hedge funds and other institutional investors have recently made changes to their positions in HSTM. GAMMA Investing LLC increased its stake in HealthStream by 5.2% in the third quarter. GAMMA Investing LLC now owns 21,686 shares of the technology company’s stock valued at $644,000 after acquiring an additional 1,076 shares during the period. Sequoia Financial Advisors LLC bought a new stake in HealthStream in the second quarter valued at about $222,000. Tidal Investments LLC acquired a new position in HealthStream in the second quarter worth about $575,000. Integrated Wealth Concepts LLC acquired a new position in HealthStream in the second quarter worth about $27,000. Finally, Squarepoint Ops LLC acquired a new position in HealthStream in the second quarter worth about $222,000. 69.58% of the stock is owned by institutional investors.

About HealthStream

HealthStream, Inc provides workforce solutions for the healthcare industry. The company develops software and services designed to help healthcare organizations manage employee learning, performance, credentialing, and other workforce-related processes.

Its offerings include online learning and education management, workforce development tools, competency and performance management, and credentialing solutions. HealthStream also provides content and administrative services intended to support regulatory compliance, professional development, and operational efficiency for healthcare employers.

Based in Nashville, Tennessee, HealthStream primarily serves healthcare organizations in the United States, including hospitals, health systems, medical practices, and other healthcare providers.